Weight Maintenance Success Of Antiobesity Medications After 1 Year Overview The high cost of novel glucagon-like peptide-1 receptor agonists (GLP-1 RAs) often limits their accessibility, creating significant barriers to care. This study explored the effectiveness of older, generic anti-obesity medications (AOMs) in sustaining weight loss after a year of GLP-1
Tag: GLP-1 receptor agonist therapy
